Merck SEC filings: 8-K
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedMerck raises 2026 non-GAAP EPS outlook to $2.77-$2.82 after third-quarter non-GAAP EPS of $2.49 beats $2.09 consensus, though GAAP EPS fell 12% to $2.04
Departure/appointment of directors or officers
AI summary, unreviewedMerck & Co. (MRK) Adds Paul J. Diaz to Board Effective November 1, 2026, Board Grows to 14 Members
Results of operations and financial condition · Financial statements and exhibits